DAFNA Capital Management LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 78 filers reported holding TRANSLATE BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$10,382,000
+179.3%
376,993
+67.3%
2.17%
+146.1%
Q1 2021$3,717,000
-10.5%
225,3930.0%0.88%
-28.6%
Q4 2020$4,154,000
+59.8%
225,393
+18.1%
1.24%
+46.3%
Q3 2020$2,599,000
+77.5%
190,930
+6.2%
0.84%
+68.0%
Q4 2019$1,464,000
-59.4%
179,845
-50.6%
0.50%
-63.0%
Q3 2019$3,610,000
+60.3%
364,229
+104.3%
1.36%
+60.3%
Q2 2019$2,252,000
+31.2%
178,306
-22.1%
0.85%
-0.8%
Q4 2018$1,717,000
+13.2%
228,939
+50.9%
0.85%
+37.1%
Q3 2018$1,517,000
+499.6%
151,739
+658.7%
0.62%
+428.0%
Q2 2018$253,00020,0000.12%
Other shareholders
TRANSLATE BIO INC shareholders Q4 2019
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders